We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 4,974 results
  1. IGL CDR3 Hydropathy and Antigen Chemical Complementarity Associated with Greater Disease-Free Survival in Lung Adenocarcinoma: Implications for Gender Disparities

    With lung cancer remaining a challenging disease, new approaches to biomarker discovery and therapy development are needed. Recent immunogenomics,...

    Shaun V. Charkowick, Taha I. Huda, ... George Blanck in Biochemical Genetics
    Article 01 July 2023
  2. Tumour stroma ratio is a potential predictor for 5-year disease-free survival in breast cancer

    Background

    The tumour–stroma ratio (TSR) is identified as a promising prognostic parameter for breast cancer, but the cutoff TSR value is mostly...

    Dandan Yan, ** Yuan in BMC Cancer
    Article Open access 21 October 2022
  3. MMP-11 expression in early luminal breast cancer: associations with clinical, MRI, pathological characteristics, and disease-free survival

    Background

    Early hormone-positive breast cancers typically have favorable outcomes, yet long-term surveillance is crucial due to the risk of late...

    Sébastien Molière, Massimo Lodi, ... Catherine Tomasetto in BMC Cancer
    Article Open access 04 March 2024
  4. Predicting disease-free survival in colorectal cancer by circulating tumor DNA methylation markers

    Background

    Recurrence represents a well-known poor prognostic factor for colorectal cancer (CRC) patients. This study aimed to establish an effective...

    **n Yang, **aofeng Wen, ... **anrui Wu in Clinical Epigenetics
    Article Open access 01 December 2022
  5. Associations of different immune checkpoints-expressing CD4+ Treg/ T cell subsets with disease-free survival in colorectal cancer patients

    There are different subsets of T regulatory cells (Tregs), orchestrating critical roles in the regulation of anti-tumor immunity in colorectal cancer...

    Mohammad A. Al-Mterin, Khaled Murshed, ... Eyad Elkord in BMC Cancer
    Article Open access 02 June 2022
  6. Type of adjuvant endocrine therapy and disease-free survival in patients with early HR-positive/HER2-positive BC: analysis from the phase III randomized ShortHER trial

    The optimal adjuvant endocrine therapy for HR-positive/HER2-positive breast cancer patients is unknown. We included in this analysis 784 patients...

    Maria Vittoria Dieci, Giancarlo Bisagni, ... Valentina Guarneri in npj Breast Cancer
    Article Open access 04 February 2023
  7. Identification of Plasma Metabolites Associated with Lung Cancer Survival

    Limited knowledge has been reported regarding the performance of plasma metabolomics for predicting lung cancer prognosis. In this chapter, we...
    Peiyu Wang, Yuyao Yuan, Mantang Qiu in Liquid Biopsies
    Protocol 2023
  8. Breast cancer treatment and its impact on survival in Morocco: a study over a decade

    Background

    In Morocco, much progress has been made in breast cancer treatment. However, there is limited information on survival outcomes of breast...

    Hind Mrabti, Catherine Sauvaget, ... Partha Basu in BMC Cancer
    Article Open access 01 July 2024
  9. Increased resected lymph node stations improved survival of esophageal squamous cell carcinoma

    Background

    Neoadjuvant chemoradiotherapy (nCRT) and surgery have been recommended as the standard treatments for locally advanced esophageal squamous...

    Run-Da Lu, Zheng-Dao Wei, ... Long-Qi Chen in BMC Cancer
    Article Open access 05 February 2024
  10. Survival outcomes in locally advanced dMMR rectal cancer: surgery plus adjunctive treatment vs. surgery alone

    Background

    Recent studies have shown that deficient mismatch repair (dMMR) rectal cancer may be related to treatment resistance, resulting in a worse...

    Kemin Ni, Yixiang Zhan, ... Chunze Zhang in BMC Cancer
    Article Open access 20 October 2023
  11. Inflammatory markers predict survival in patients with postoperative urothelial carcinoma receiving tislelizumab (PD-1 inhibitor) adjuvant therapy

    Background

    In the management of urothelial carcinoma, patient selection for immunotherapy, particularly with immune checkpoint inhibitors such as...

    Meng Yang, **gwen Zhang, ... Haitao Zhu in BMC Cancer
    Article Open access 12 February 2024
  12. Body mass index and absolute lymphocyte count predict disease-free survival in Korean breast cancer patients

    Background

    Our study evaluated the association between body mass index (BMI) and absolute lymphocyte count (ALC) in breast cancer patients and healthy...

    Sung Min Ko, Janghee Lee, ... Joon Jeong in British Journal of Cancer
    Article Open access 19 April 2021
  13. Long-term survival after neoadjuvant therapy for triple-negative breast cancer under different treatment regimens: a systematic review and network meta-analysis

    Background

    Triple-negative breast cancer (TNBC) is a life-threatening subtype of breast cancer with limited treatment options. Therefore, this network...

    Zhilin Liu, **ming Li, ... Jiuda Zhao in BMC Cancer
    Article Open access 09 April 2024
  14. A multi-parametric prognostic model based on clinicopathologic features: vessels encapsulating tumor clusters and hepatic plates predict overall survival in hepatocellular carcinoma patients

    Background

    Vessels encapsulating tumor clusters (VETC) is a newly described vascular pattern that is distinct from microvascular invasion (MVI) in...

    Si-** **ong, Chun-Hua Wang, ... Li-Li Liu in Journal of Translational Medicine
    Article Open access 18 May 2024
  15. Effect of different surgical approaches on the survival and safety of Siewert type II esophagogastric junction adenocarcinoma: a systematic review and meta-analysis

    Background

    Whether a transthoracic (TT) procedure by a thoracic surgeon or a transabdominal (TA) by a gastrointestinal surgeon is best for Siewert...

    Hongyang Zheng, **ngmei Yin, ... Zhenjia Li in BMC Cancer
    Article Open access 21 November 2023
  16. Effect of histological breast cancer subtypes invasive lobular versus non-special type on survival in early intermediate-to-high-risk breast carcinoma: results from the SUCCESS trials

    Background

    Invasive lobular breast carcinomas (ILC) have different histological features compared to non-special type carcinomas (NST), but the effect...

    Davut Dayan, Stefan Lukac, ... Thomas W. P. Friedl in Breast Cancer Research
    Article Open access 14 December 2023
  17. Tumour infiltrating lymphocytes and survival after adjuvant chemotherapy in patients with gastric cancer: post-hoc analysis of the CLASSIC trial

    Background

    Only a subset of gastric cancer (GC) patients with stage II–III benefits from chemotherapy after surgery. Tumour infiltrating lymphocytes...

    Drolaiz H. W. Liu, Young-Woo Kim, ... Heike I. Grabsch in British Journal of Cancer
    Article 07 April 2023
  18. Prospective cohort of pre- and post-diagnosis alcohol consumption and cigarette smoking on survival outcomes: an Alberta Endometrial Cancer Cohort Study

    Purpose

    To examine the independent and joint relationships between cigarette smoking and alcohol consumption with survival outcomes after endometrial...

    Renée L. Kokts-Porietis, Andria R. Morielli, ... Christine M. Friedenreich in Cancer Causes & Control
    Article 19 August 2023
  19. Sleep and cancer recurrence and survival in patients with resected Stage III colon cancer: findings from CALGB/SWOG 80702 (Alliance)

    Background

    We sought to assess the influences of sleep duration, sleep adequacy, and daytime sleepiness on survival outcomes among Stage III colon...

    Seohyuk Lee, Chao Ma, ... Jeffrey A. Meyerhardt in British Journal of Cancer
    Article 13 May 2023
  20. Cytoplasmic poly(A)-binding protein 1 (PABPC1) is a prognostic biomarker to predict survival in nasopharyngeal carcinoma regardless of chemoradiotherapy

    Background

    Nasopharyngeal carcinoma (NPC), especially the nonkeratinizing type, is a malignant tumor primarily occurring in southern China and...

    Feng Ling, Shengen Xu, ... Wenbo Long in BMC Cancer
    Article Open access 20 February 2023
Did you find what you were looking for? Share feedback.